High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma

Background: Esophageal squamous cell carcinoma (ESCC) is the major type of esophageal cancer in Asia and demonstrates poor survival rates following a therapeutic regimen. Methods: Cancer stem cells (CSCs) are responsible for tumor initiation, progression, and treatment failure in cancers. Therefore,...

Full description

Bibliographic Details
Main Authors: Cheng-Han Lin, Hao-Yi Li, Yu-Peng Liu, Pei-Fung Kuo, Wen-Ching Wang, Forn-Chia Lin, Wei-Lun Chang, Bor-Shyang Sheu, Yi-Ching Wang, Wan-Chun Hung, Hui-Chuan Cheng, Yun-Chin Yao, Marcus J. Calkins, Michael Hsiao, Pei-Jung Lu
Format: Article
Language:English
Published: SAGE Publishing 2019-09-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835919875324
_version_ 1818244693412020224
author Cheng-Han Lin
Hao-Yi Li
Yu-Peng Liu
Pei-Fung Kuo
Wen-Ching Wang
Forn-Chia Lin
Wei-Lun Chang
Bor-Shyang Sheu
Yi-Ching Wang
Wan-Chun Hung
Hui-Chuan Cheng
Yun-Chin Yao
Marcus J. Calkins
Michael Hsiao
Pei-Jung Lu
author_facet Cheng-Han Lin
Hao-Yi Li
Yu-Peng Liu
Pei-Fung Kuo
Wen-Ching Wang
Forn-Chia Lin
Wei-Lun Chang
Bor-Shyang Sheu
Yi-Ching Wang
Wan-Chun Hung
Hui-Chuan Cheng
Yun-Chin Yao
Marcus J. Calkins
Michael Hsiao
Pei-Jung Lu
author_sort Cheng-Han Lin
collection DOAJ
description Background: Esophageal squamous cell carcinoma (ESCC) is the major type of esophageal cancer in Asia and demonstrates poor survival rates following a therapeutic regimen. Methods: Cancer stem cells (CSCs) are responsible for tumor initiation, progression, and treatment failure in cancers. Therefore, identification and characterization of CSCs may help to improve clinical outcomes for ESCC patients. Tumor sphere formation assay are performed to isolate cancer stem-like ESCC cells. QRT-PCR, tumor initiation, metastasis, CCRT treatment are used to evaluate ESCC cells’ stemness properties in vitro and in vivo . Results: The authors’ data demonstrates that cancer stem-like ESCC cells harbored stemness characteristics including self-renewal, differentiation, and transdifferentiation, and possess tumor initiation, metastasis, and treatment inefficiency properties. For the identification of useful biomarkers of cancer stem-like ESCC cells, the authors further identified that CLDN4 was upregulated in cancer stem-like ESCC cells when compared with bulk cancer cells. High-CLDN4 cells harbored stemness and cisplatin/concurrent chemoradiation therapy (CCRT) resistance properties and a high level of CLDN4 was correlated with poor prognosis and poor CCRT response in ESCC patients. Importantly, thiamine tetrahydrofurfuryl disulfide (TTFD) decreased CLDN4 and attenuated stemness in ESCC cells, and TTFD combined with CCRT improved CCRT response in vivo . Conclusions: CLDN4 was suggested as prognostic and a CCRT response indicator for ESCC patients. TTFD combined with CCRT has potential to improve ESCC patient’s clinical outcomes in the future.
first_indexed 2024-12-12T14:21:05Z
format Article
id doaj.art-b18e9d44a0d441e58728c73a619a16f4
institution Directory Open Access Journal
issn 1758-8359
language English
last_indexed 2024-12-12T14:21:05Z
publishDate 2019-09-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Medical Oncology
spelling doaj.art-b18e9d44a0d441e58728c73a619a16f42022-12-22T00:21:47ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83592019-09-011110.1177/1758835919875324High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinomaCheng-Han LinHao-Yi LiYu-Peng LiuPei-Fung KuoWen-Ching WangForn-Chia LinWei-Lun ChangBor-Shyang SheuYi-Ching WangWan-Chun HungHui-Chuan ChengYun-Chin YaoMarcus J. CalkinsMichael HsiaoPei-Jung LuBackground: Esophageal squamous cell carcinoma (ESCC) is the major type of esophageal cancer in Asia and demonstrates poor survival rates following a therapeutic regimen. Methods: Cancer stem cells (CSCs) are responsible for tumor initiation, progression, and treatment failure in cancers. Therefore, identification and characterization of CSCs may help to improve clinical outcomes for ESCC patients. Tumor sphere formation assay are performed to isolate cancer stem-like ESCC cells. QRT-PCR, tumor initiation, metastasis, CCRT treatment are used to evaluate ESCC cells’ stemness properties in vitro and in vivo . Results: The authors’ data demonstrates that cancer stem-like ESCC cells harbored stemness characteristics including self-renewal, differentiation, and transdifferentiation, and possess tumor initiation, metastasis, and treatment inefficiency properties. For the identification of useful biomarkers of cancer stem-like ESCC cells, the authors further identified that CLDN4 was upregulated in cancer stem-like ESCC cells when compared with bulk cancer cells. High-CLDN4 cells harbored stemness and cisplatin/concurrent chemoradiation therapy (CCRT) resistance properties and a high level of CLDN4 was correlated with poor prognosis and poor CCRT response in ESCC patients. Importantly, thiamine tetrahydrofurfuryl disulfide (TTFD) decreased CLDN4 and attenuated stemness in ESCC cells, and TTFD combined with CCRT improved CCRT response in vivo . Conclusions: CLDN4 was suggested as prognostic and a CCRT response indicator for ESCC patients. TTFD combined with CCRT has potential to improve ESCC patient’s clinical outcomes in the future.https://doi.org/10.1177/1758835919875324
spellingShingle Cheng-Han Lin
Hao-Yi Li
Yu-Peng Liu
Pei-Fung Kuo
Wen-Ching Wang
Forn-Chia Lin
Wei-Lun Chang
Bor-Shyang Sheu
Yi-Ching Wang
Wan-Chun Hung
Hui-Chuan Cheng
Yun-Chin Yao
Marcus J. Calkins
Michael Hsiao
Pei-Jung Lu
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
Therapeutic Advances in Medical Oncology
title High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
title_full High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
title_fullStr High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
title_full_unstemmed High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
title_short High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
title_sort high cldn4 escc cells harbor stem like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
url https://doi.org/10.1177/1758835919875324
work_keys_str_mv AT chenghanlin highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT haoyili highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT yupengliu highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT peifungkuo highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT wenchingwang highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT fornchialin highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT weilunchang highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT borshyangsheu highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT yichingwang highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT wanchunhung highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT huichuancheng highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT yunchinyao highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT marcusjcalkins highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT michaelhsiao highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma
AT peijunglu highcldn4escccellsharborstemlikepropertiesandindicateforpoorconcurrentchemoradiationtherapyresponseinesophagealsquamouscellcarcinoma